Concepedia

Author

Harsh Shah

University of UtahORCID

Also Known As

H. Shah, Harsh R. Shah, Harsh Shah, Lipsky, Andrew, Shah, Harsh, Shah, Harsh R.

193

Publications

658

Citations

12

H-Index

7

Concepts

All Affiliations

University of UtahHuntsman Cancer InstituteRutgers, The State University of New JerseyUniversity of North Carolina at Chapel HillUniversity of Minnesota
HS

About

Harsh Shah is an author at University of Utah specializing in higher education, curriculum, and citizen science.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Education

1

1

102

2

Curriculum

1

1

102

3

Higher Education

1

1

102

4

Stem Education

1

1

102

5

Citizen Science

1

1

102

Harsh Shah

×

13

Publications

376

Citations

11

H-Index

YearCitations

Current Approaches in Implementing Citizen Science in the Classroom

Harsh Shah, Luis R. Martinez

Journal of Microbiology and Biology Education

2016

102

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Victor M. Orellana‐Noia, Daniel Reed, Ashley McCook,

Blood

2021

91

Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma

Julio C. Chávez, Francine M. Foss, Basem M. William,

Clinical Cancer Research

2023

31

Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma

Sanjal H. Desai, Michael A. Spinner, Kevin A. David,

American Journal of Hematology

2023

28

Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study

Deborah M. Stephens, Ying Huang, Amy S. Ruppert,

Clinical Cancer Research

2022

25

A Multicenter Study Assessing Interventional Pulmonary Fellow Competency in Electromagnetic Navigation Bronchoscopy

Hans J. Lee, A. Christine Argento, Hitesh Batra,

ATS Scholar

2022

15

Secondary malignancies in <scp>non‐Hodgkin</scp> lymphoma survivors: 40 years of follow‐up assessed by treatment modality

Matthew Parsons, Calvin B. Rock, Jonathan Chipman,

Cancer Medicine

2022

14

Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G‐CSF or G‐CSF and plerixafor mobilized grafts

Harsh Shah, Seongho Kim, Paramveer Singh,

American Journal of Hematology

2019

13

Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes

Charlotte B Wagner, Kenneth M. Boucher, Adrienne Nedved,

Haematologica

2023

12

PD-1 Blockade before Autologous Stem Cell Transplantation Improves Outcomes in Relapsed/Refractory Classic Hodgkin Lymphoma: Results from a Multicenter Cohort

Sanjal H. Desai, Reid W. Merryman, Harsh Shah,

Blood

2023

12

Page 1